Inflammation and Organ Failure Severely Affect Midazolam Clearance in Critically Ill Children-Reference-Cited by-同舟云学术

Inflammation and Organ Failure Severely Affect Midazolam Clearance in Critically Ill Children

Published:2016-07 Issue:1 Volume:194 Page:58-66
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Vet Nienke J.,Brussee Janneke M.,de Hoog Matthijs,Mooij Miriam G.,Verlaat Carin W. M.,Jerchel Isabel S.,van Schaik Ron H. N.,Koch Birgit C. P.,Tibboel Dick,Knibbe Catherijne A. J.,de Wildt Saskia N.

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference31 articles.

1. Pharmacokinetics and Pharmacodynamics in the Critically Ill Child

2. REGULATION OF DRUG-METABOLIZING ENZYMES AND TRANSPORTERS IN INFLAMMATION

3. The effect of inflammation on drug metabolism: a focus on pediatrics

4. Consequences of Renal Failure on Non-Renal Clearance of Drugs

5. Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Getting the dose right using physiologically-based pharmacokinetic modeling: dexamethasone to prevent post-extubation stridor in children as proof of concept;Frontiers in Pediatrics;2024-07-05

2. Combining data on the bioavailability of midazolam and physiologically‐based pharmacokinetic modeling to investigate intestinal CYP3A4 ontogeny;CPT: Pharmacometrics & Systems Pharmacology;2024-06-26

3. Applied pharmacokinetics to improve pharmacotherapy in neonatal and paediatric intensive care units: focus on correct dose selection;Archives of disease in childhood - Education & practice edition;2024-02-26

4. Performing clinical drug trials in acute and critically ill neonates and children;Essentials of Translational Pediatric Drug Development;2024

5. Advances in pharmacokinetic-pharmacodynamic modelling for pediatric drug development: extrapolations and exposure-response analyses;Expert Review of Clinical Pharmacology;2023-11-29